[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100561076":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":30,"centralContacts":34,"locations":42,"responsibleParty":196,"collaborators":25,"id":198,"slug":25,"hasResults":199,"nctId":200,"briefTitle":201,"officialTitle":202,"acronym":25,"eligibilityCriteria":203,"healthyVolunteers":199,"sex":204,"minAge":205,"maxAge":206,"enrollmentInfo":207,"targetDuration":25,"studyType":210,"phases":211,"briefSummary":213,"conditions":214,"keywords":216,"overallStatus":45,"whyStopped":25,"lastUpdateSubmitDate":222,"lastUpdatePostDateStruct":223,"startDateStruct":226,"completionDateStruct":228,"leadSponsor":230,"locationsCount":231},{"fullName":5,"class":6},"Alnylam Pharmaceuticals","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"ALN-HTT02","EXPERIMENTAL","Participants will be administered a single dose of ALN-HTT02 during the Double-blind Part of the study. Participants who received ALN-HTT02 in the Double-blind part of the study will not receive an additional dose during the Open-label Part of the study. Participants have the option to receive repeat doses of ALN-HTT02 in the Open-label Extension (OLE) Part of the study.",[13],"Drug: ALN-HTT02",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo + ALN-HTT02","PLACEBO_COMPARATOR","Participants will be administered a single dose of placebo during the Double-blind Part of the study. Participants will have the option to receive a single dose of ALN-HTT02 during the Open-label Part of the study. Participants have the option to receive repeat doses of ALN-HTT02 in the OLE Part of the study.",[13,19],"Drug: Placebo",[21,26],{"type":22,"name":9,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","ALN-HTT02 will be administered intrathecally",[9,15],null,{"type":22,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Placebo","Placebo will be administered intrathecally",[15],[31],{"name":32,"affiliation":5,"role":33},"Medical Director","STUDY_DIRECTOR",[35,40],{"name":36,"role":37,"phone":38,"phoneExt":25,"email":39},"Alnylam Clinical Trial Information Line","CONTACT","1-877-ALNYLAM","clinicaltrials@alnylam.com",{"name":36,"role":37,"phone":41,"phoneExt":25,"email":39},"1-877-256-9526",[43,55,63,71,79,88,96,104,112,120,128,136,145,153,161,169,172,180,188],{"facility":44,"status":45,"city":46,"state":25,"zip":47,"country":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":25},"Clinical Trial Site","RECRUITING","Edmonton","T6G 2B7","Canada",{"type":50,"coordinates":51},"Point",[52,53],-113.46871,53.55014,{"lat":53,"lon":52},{"facility":44,"status":45,"city":56,"state":25,"zip":57,"country":48,"cosmosGeoPoint":58,"geoPoint":62,"contacts":25},"Montreal","H2W 1T8",{"type":50,"coordinates":59},[60,61],-73.58781,45.50884,{"lat":61,"lon":60},{"facility":44,"status":45,"city":64,"state":25,"zip":65,"country":48,"cosmosGeoPoint":66,"geoPoint":70,"contacts":25},"Ottawa","K1Y4E9",{"type":50,"coordinates":67},[68,69],-75.69812,45.41117,{"lat":69,"lon":68},{"facility":44,"status":45,"city":72,"state":25,"zip":73,"country":48,"cosmosGeoPoint":74,"geoPoint":78,"contacts":25},"Vancouver","V6T 2B5",{"type":50,"coordinates":75},[76,77],-123.11934,49.24966,{"lat":77,"lon":76},{"facility":44,"status":45,"city":80,"state":25,"zip":81,"country":82,"cosmosGeoPoint":83,"geoPoint":87,"contacts":25},"Berlin","10117","Germany",{"type":50,"coordinates":84},[85,86],13.41053,52.52437,{"lat":86,"lon":85},{"facility":44,"status":45,"city":89,"state":25,"zip":90,"country":82,"cosmosGeoPoint":91,"geoPoint":95,"contacts":25},"Bochum","44791",{"type":50,"coordinates":92},[93,94],7.21648,51.48165,{"lat":94,"lon":93},{"facility":44,"status":45,"city":97,"state":25,"zip":98,"country":82,"cosmosGeoPoint":99,"geoPoint":103,"contacts":25},"Bonn","53127",{"type":50,"coordinates":100},[101,102],7.09549,50.73438,{"lat":102,"lon":101},{"facility":44,"status":45,"city":105,"state":25,"zip":106,"country":82,"cosmosGeoPoint":107,"geoPoint":111,"contacts":25},"Dresden","01307",{"type":50,"coordinates":108},[109,110],13.73832,51.05089,{"lat":110,"lon":109},{"facility":44,"status":45,"city":113,"state":25,"zip":114,"country":82,"cosmosGeoPoint":115,"geoPoint":119,"contacts":25},"Münster","48149",{"type":50,"coordinates":116},[117,118],7.62571,51.96236,{"lat":118,"lon":117},{"facility":44,"status":45,"city":121,"state":25,"zip":122,"country":82,"cosmosGeoPoint":123,"geoPoint":127,"contacts":25},"Taufkirchen","84416",{"type":50,"coordinates":124},[125,126],11.61701,48.0486,{"lat":126,"lon":125},{"facility":44,"status":45,"city":129,"state":25,"zip":130,"country":82,"cosmosGeoPoint":131,"geoPoint":135,"contacts":25},"Ulm","89081",{"type":50,"coordinates":132},[133,134],9.99155,48.39841,{"lat":134,"lon":133},{"facility":44,"status":45,"city":137,"state":25,"zip":138,"country":139,"cosmosGeoPoint":140,"geoPoint":144,"contacts":25},"Birmingham","B15 2TT","United Kingdom",{"type":50,"coordinates":141},[142,143],-1.89983,52.48142,{"lat":143,"lon":142},{"facility":44,"status":45,"city":146,"state":25,"zip":147,"country":139,"cosmosGeoPoint":148,"geoPoint":152,"contacts":25},"Cambridge","CB2 0PY",{"type":50,"coordinates":149},[150,151],0.11667,52.2,{"lat":151,"lon":150},{"facility":44,"status":45,"city":154,"state":25,"zip":155,"country":139,"cosmosGeoPoint":156,"geoPoint":160,"contacts":25},"Cardiff","CF103AX",{"type":50,"coordinates":157},[158,159],-3.18,51.48,{"lat":159,"lon":158},{"facility":44,"status":45,"city":162,"state":25,"zip":163,"country":139,"cosmosGeoPoint":164,"geoPoint":168,"contacts":25},"Glasgow","G51 4TF",{"type":50,"coordinates":165},[166,167],-4.25763,55.86515,{"lat":167,"lon":166},{"facility":44,"status":45,"city":170,"state":25,"zip":171,"country":139,"cosmosGeoPoint":25,"geoPoint":25,"contacts":25},"Greater Manchester","M13 9WL",{"facility":44,"status":45,"city":173,"state":25,"zip":174,"country":139,"cosmosGeoPoint":175,"geoPoint":179,"contacts":25},"London","WC1N 3BG",{"type":50,"coordinates":176},[177,178],-0.12574,51.50853,{"lat":178,"lon":177},{"facility":44,"status":45,"city":181,"state":25,"zip":182,"country":139,"cosmosGeoPoint":183,"geoPoint":187,"contacts":25},"Oxford","OX3 9DU",{"type":50,"coordinates":184},[185,186],-1.25596,51.75222,{"lat":186,"lon":185},{"facility":44,"status":45,"city":189,"state":25,"zip":190,"country":139,"cosmosGeoPoint":191,"geoPoint":195,"contacts":25},"Plymouth","PL6 8DH",{"type":50,"coordinates":192},[193,194],-4.14305,50.37153,{"lat":194,"lon":193},{"type":197,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100561076",false,"NCT06585449","A Study to Evaluate ALN-HTT02 in Adult Patients With Huntington's Disease","A Randomized, Double-blind, Placebo-controlled Study, to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally Administered Single Ascending Doses of ALN-HTT02 in Adult Patients With Huntington's Disease","Inclusion Criteria\n\n* Has stage 2 or early Stage 3 Huntington's disease (HD), per the Huntington's Disease Integrated Staging System (HD-ISS)\n\nExclusion Criteria\n\n* Has significant structural or degenerative neurologic disease other than Huntington's Disease (HD) at screening\n* Has primary or secondary immune compromise at screening due to infections, medical conditions, or chronic therapies\n* Has alanine aminotransferase or aspartate aminotransferase \\>2× upper limit of normal (ULN)\n* Has an estimated glomerular filtration rate (eGFR) of \\\u003C60 mL\u002Fmin\u002F1.73m\\^2 at screening\n* Has received an investigational agent within the last 1 year or 5 half-lives (if known)\n\nNote: other protocol defined inclusion \u002F exclusion criteria apply","ALL","25 Years","70 Years",{"count":208,"type":209},66,"ESTIMATED","INTERVENTIONAL",[212],"PHASE1","The purpose of this study is to evaluate the safety, tolerability, pharmacodynamics (PD) and pharmacokinetics (PK) of single or repeat doses of ALN-HTT02.",[215],"Huntington's Disease",[217,9,218,219,220,221],"siRNA","Intrathecal","HD-ISS Stage 2","HD-ISS early Stage 3","Neurodegenerative disorder","2026-06-10",{"date":224,"type":225},"2026-06-12","ACTUAL",{"date":227,"type":225},"2024-10-14",{"date":229,"type":209},"2028-07-05",{"name":5,"class":6},19]